Skip to main content


Advances in Therapy

Advances in Therapy OnlineFirst articles

06.08.2020 | Original Research Open Access

Clinical and Economic Burden of Chronic Heart Failure and Reduced Ejection Fraction Following a Worsening Heart Failure Event

The prevalence of heart failure (HF) in the USA is predicted to increase by 46% from 2012 to 2030, resulting in more than eight million adults 18 years or older having HF with nearly $70 billion in associated health care costs [ 1 ]. HF leads to …

04.08.2020 | Brief Report Open Access

Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

Effective pangenotypic hepatitis C virus (HCV) treatment is available through all-oral direct-acting antiviral (DAA) therapies [ 1 ]. However, despite the availability of these treatments, prevalence of HCV remains high, often due to a lack of …

01.08.2020 | Review Open Access

Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Diseases: A Narrative Review

Immune-mediated inflammatory diseases (IMIDs) are chronic conditions that create a significant disease burden on millions of patients while adding a major financial burden to societies and healthcare systems. The introduction of biologic medicines …

31.07.2020 | Original Research

A Comparison of Analgesia After a Thoracoscopic Lung Cancer Operation with a Sustained Epidural Block and a Sustained Paravertebral Block: A Randomized Controlled Study

Regional block analgesia technology, which has an incomparable advantage over the systemic administration of analgesia in patients’ pain control, particularly reduces postoperative chronic pain [ 1 , 2 ]. Thoracic surgery was considered to be the …

29.07.2020 | Review Open Access

Postnatal Care of Woman with Rheumatic Diseases

Caring for women in the postnatal period can be challenging. One of the most important aspects is ensuring disease control as there is a risk of flare in the postpartum period. Other aspects of care also need to be addressed with the mother in …

Aktuelle Ausgaben

Über diese Zeitschrift

Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

Advances in Therapy is of interest to a broad audience of researchers, industry and healthcare professionals, receiving submissions from all over the world, and publishes original research and authoritative reviews focusing on new and existing therapies and interventions, areas of unmet need and general topics of interest to the medical community.

Moving forward from traditional publishing, Advances in Therapy offers a range of additional features designed to increase visibility and readership. Each paper is accompanied by a bulleted slide summary, giving a time-efficient overview of the content to a wider readership. Articles also have the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are open access and are peer reviewed to the same high standard as the article itself.

Upon acceptance of your article for publication, you will be required to pay an article processing charge of £420/$660 per typeset page. Additionally, Advances in Therapy offers an open access option for all articles submitted to the journal. If you choose open access publication you will be required to pay an additional fee of £2000/$3000 upon acceptance of your article.

Please note: Advances in Therapy's open access articles are published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here:

For more information about the journal, please contact or see the News page for the latest journal offers.

Weitere Informationen

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin